Contracts › 75F40123C00103
75F40123C00103: FY23C1EWP5 Development of Neuroblastoma Tissue Diagnostic Utility Through Fusion of Deep Learning-Based Image Analytics and Targeted Multiplex Proteomics
Awarded to The Leland Stanford Junior University by Food and Drug Administration (FDA).
$1.7Mobligated
$1.7Mpotential value
30 January 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40123C00103 |
|---|---|
| Awardee | The Leland Stanford Junior University |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | B504 Special Studies/Analysis- Chemical/Biological |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 20 September 2023 to 30 January 2027 |
| Potential end | 30 January 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record